1. The global anesthesia and respiratory devices market is expected to be primarily driven by the huge patient population suffering from obstructive sleep apnea and chronic obstructive pulmonary disease and the availability of medical devices to treat OSA and COPD.
2. The global anesthesia and respiratory devices market is forecast to exceed $13 billion by 2016, with a compound annual growth rate of 9 percent from 2009-2016.
3. The United States is the biggest market for anesthesia and respiratory devices, contributing 49 percent towards the global market in 2009, and this contribution is expected to increase to 54 percent by 2016.
4. The U.S. market is expected to be driven by those patients suffering from OSA (15 million) and COPD (12 million), the availability of reimbursement for anesthesia and respiratory devices and the growth in the home healthcare equipment market.
5. In 2009, Draegerwerk AG & Co. KGaA, Covidien, GE Healthcare and Philips Respironics were the leading players in the anesthesia and respiratory devices market with a combined market share of 42 percent. Draegerwerk AG & Co. KGaA and GE Healthcare dominate the anesthesia machines market. Philips Respironics is one of the leading players in the respiratory devices market and Covidien is the market leader in the respiratory measurement devices market.
Learn more about “The Future of Anesthesia and Respiratory Devices, Competitive Landscape and Forecasts to 2016.”
Read more coverage about anesthesia:
– ASA President Offers 7 Reasons to Question Anesthesia Cost-Containment Study
– Anesthesiologist Elected as President of AAPS
– Massachusetts Anesthesiologist and Pain Management Specialist Sentenced for Healthcare Fraud
